article · Modern Journal of Statistics
Measures like Value-at-Risk (VaR), Tail Value-at-Risk (TVaR), Mean-of-Order-P (MOO-P), and Peaks Over a Random Threshold VaR (PORT-VaR) are important in risk analysis, particularly when it comes to medical data. In order to better capture extreme occurrences in medical applications, this work presents the Extended Rayleigh-Fréchet (ER-Fr) model, a novel extreme value distribution. We derive and discuss several of their key mathematical and statistical properties that are particularly useful for risk assessment. A comprehensive simulation study is conducted to evaluate the performance of the maximum likelihood estimators under various sample sizes, confirming the model’s reliability. The practical utility of the ER-Fr distribution is demonstrated through the analysis of two real medical datasets: one on relief times for arthritic patients and another on survival times of guinea pigs exposed to tuberculosis. The model is compared with several existing Fréchet-type distributions using standard goodness-of-fit criteria, and it consistently outperforms its competitors. Based on this analysis, we provide actionable insights and recommendations for healthcare practitioners and risk analysts. The results highlight the ER-Fr model as a powerful and flexible tool for modeling extreme values and assessing risk in medical studies.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.64389/mjs.2026.02260
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.